The World's Greatest Investing Community
Results 71 - 80 of 516 : Previous 4 5 6 7 8 9 10 11 12 Next
Amgen's Long Shot Comes Up Short
Lung cancer is one tough cookie.
Does Pfizer Pass Buffett's Test?
Here's one of Buffett's favorite metrics for evaluating companies.
Should Big Biotech Pay Dividends?
All grown up and no payouts to offer.
Whoa! What Just Happened to My Stock?
These stocks just took off, but are they about to make a return trip to Earth?
Why Some Great Stocks Are Never Cheap
Value investors often miss out on the best-performing stocks.
Keep your eye on margins.
Gilead Gears Up to Fight Cancer
Gilead has been infected by the diversification bug.
Celgene's Management Is Creating Value
What EVA momentum shows us about the folks running Celgene.
Sometimes, the harder you throw a ball, the higher it bounces.
Will it be Abraxane?
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK